Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Marsh & Mclennan Companies (MRSH) over the last 17 years, with Q4 2025 value amounting to $11.5 billion.

  • Marsh & Mclennan Companies' Cash & Equivalents rose 174.71% to $11.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.5 billion, marking a year-over-year increase of 174.71%. This contributed to the annual value of $11.5 billion for FY2025, which is 174.71% up from last year.
  • As of Q4 2025, Marsh & Mclennan Companies' Cash & Equivalents stood at $11.5 billion, which was up 174.71% from $12.0 billion recorded in Q3 2025.
  • Marsh & Mclennan Companies' Cash & Equivalents' 5-year high stood at $12.0 billion during Q3 2025, with a 5-year trough of $772.0 million in Q1 2022.
  • In the last 5 years, Marsh & Mclennan Companies' Cash & Equivalents had a median value of $11.0 billion in 2023 and averaged $7.3 billion.
  • Per our database at Business Quant, Marsh & Mclennan Companies' Cash & Equivalents plummeted by 4810.05% in 2021 and then soared by 137481.3% in 2023.
  • Marsh & Mclennan Companies' Cash & Equivalents (Quarter) stood at $1.8 billion in 2021, then surged by 508.45% to $10.7 billion in 2022, then increased by 1.26% to $10.8 billion in 2023, then increased by 4.47% to $11.3 billion in 2024, then increased by 1.75% to $11.5 billion in 2025.
  • Its Cash & Equivalents stands at $11.5 billion for Q4 2025, versus $12.0 billion for Q3 2025 and $11.9 billion for Q2 2025.